kawasaki
diseas
subsequ
coronari
aneur
first
report
japanes
pediatrician
tomisaku
kawasaki
kawasaki
date
mani
case
report
countri
burn
glode
sever
investig
reveal
kawasaki
diseas
consist
system
vascul
hypercytokinemia
furukawa
et
al
mauri
et
al
ueno
et
al
matsubara
et
al
eberhard
et
al
asano
ogawa
number
report
indic
develop
kawasaki
diseas
might
associ
bacteri
viral
infect
caus
staphylococcu
aureu
hemolyt
streptococcu
yersinia
viru
human
human
coronaviru
kikuta
et
al
akiyama
yashiro
leung
et
al
abe
et
al
ihira
et
al
esper
et
al
howev
etiolog
kawasaki
diseas
still
controversi
sever
investig
demonstr
coronari
arter
experiment
anim
dilat
coronari
arteri
develop
murata
lehman
et
al
philip
et
al
howev
model
directli
applic
clinic
phenomenon
method
induct
base
clinic
observ
flare
crust
format
bacillu
bcg
inocul
site
one
typic
symptom
kawasaki
diseas
list
diagnost
criteria
probabl
immunopatholog
respons
sato
et
al
kuniyuki
asada
ayusawa
et
al
although
princip
symptom
kawasaki
diseas
allow
earli
diagnosi
case
respons
indic
immun
respons
bcg
antigen
resid
intraderm
vaccin
recipi
might
boost
system
vascul
occur
patient
kawasaki
diseas
antibodi
mycobacteri
heat
shock
protein
increas
recogn
conserv
peptid
human
homolog
suggest
crossreact
immun
respons
bcg
human
antigen
might
caus
immunopathogenesi
lead
system
vascul
sireci
et
al
yokota
et
al
autoantibodi
antineutrophil
antibodi
anca
antiendotheli
cell
antibodi
aeca
known
associ
autoimmun
vascul
belizna
tervaert
bosch
et
al
report
elsewher
aeca
found
patient
kawasaki
diseas
kaneko
et
al
recent
karasawa
et
al
report
autoantibodi
peroxiredoxin
ii
found
predominantli
sera
patient
autoimmun
diseas
system
vascul
karasawa
et
al
ozaki
homolog
peroxiredoxin
ii
also
conserv
mani
microorgan
homolog
also
express
bcg
higher
level
mycobacterium
tuberculosi
springer
et
al
thu
crossreact
immun
respons
might
trigger
microorgan
possess
crossreact
antigen
could
associ
develop
kawasaki
diseas
describ
mani
report
indic
kawasaki
diseas
associ
infect
therefor
hypothes
infecti
agent
antigen
protein
homolog
bcg
vascular
wall
might
induc
immunopatholog
reaction
lesion
bcg
vaccin
site
vascular
wall
studi
examin
whether
coronari
arter
develop
combin
primari
immun
bcg
secondari
immun
ubiquit
microorgan
mycobacterium
intracellurar
cmi
share
crossreact
antigen
model
demonstr
coronari
arter
cytokinemia
similar
found
kawasaki
diseas
furthermor
show
administr
antibodi
compon
vascular
endotherium
peroxiredoxin
ii
bcg
prime
also
induc
coronari
arter
indic
immunopatholog
reaction
caus
coronari
arter
requir
prior
bcg
immun
bcg
tokyo
strain
purchas
nihon
bcg
inc
tokyo
japan
mycobacterium
intracellular
mi
jcm
number
obtain
japanes
collect
microorgan
riken
bioresourc
center
saitama
japan
purchas
antiperoxiredoxin
ii
polyclon
antibodi
lab
frontier
seoul
korea
antibodi
obtain
rabbit
immun
recombin
human
peroxyredoxin
ii
purifi
escherichia
coli
antibodi
also
recogn
mous
rat
homolog
follow
procedur
lehman
et
al
obtain
crude
lysat
inject
lehman
et
al
mi
cultur
middlebrook
broth
difco
detroit
mi
h
harvest
centrifug
g
min
wash
three
time
phosphatebuff
salin
pb
ph
g
min
bacteria
lyse
overnight
incub
room
temperatur
volum
sodium
dodecyl
sulfat
sd
em
scienc
gibbstown
nj
wash
time
pb
remov
supernat
sd
bacteri
lysat
incub
sequenti
rnase
dnase
trypsin
sigma
st
loui
mo
h
centrifug
pellet
wash
four
time
pb
crude
lysat
obtain
sonic
pellet
g
wet
weight
ml
pb
ice
h
puls
paus
fix
frequenc
khz
sonic
prepar
centrifug
h
g
supernat
harvest
inject
wet
volum
ultracentrifug
pellet
adjust
final
concentr
mg
pb
femal
mice
week
age
purchas
sankyo
laboratori
tokyo
japan
bcg
mg
ml
salin
salin
control
inocul
intraderm
left
flank
observ
nodular
format
inocul
site
ml
purifi
protein
deriv
ppd
inject
intraderm
skin
test
ascertain
immun
cutan
reaction
observ
h
inject
four
week
bcg
immun
mice
intraderm
inject
either
mg
crude
mi
lysat
cmi
ml
pb
pb
control
either
one
four
daili
dose
experiment
group
mice
administ
rabbit
antiserum
mice
peroxiredoxin
ii
pb
control
tail
vein
week
bcg
immun
ten
day
cmi
inject
administr
peroxiredoxin
ii
antibodi
sera
collect
jugular
vein
specimen
histolog
analysi
prepar
describ
previous
nakamura
et
al
briefli
anim
sacrif
anesthesia
heart
excis
embed
oct
compound
sakura
finetechn
co
ltd
tokyo
japan
store
serial
section
width
made
use
cryostat
experi
bodi
weight
rectal
temperatur
mice
monitor
time
bcg
inocul
everi
day
upon
secondari
immun
antibodi
administr
serial
section
base
apex
heart
stain
hematoxylin
eosin
evalu
coronari
arter
eight
section
anim
evalu
five
eyefield
observ
section
criteria
coronari
arter
follow
mild
defin
infiltr
inflammatori
cell
surround
arteri
wall
sever
defin
infiltr
inflammatori
cell
within
layer
arteri
wall
amount
tumor
necrosi
interleukin
il
monocyt
chemoattract
anim
sera
evalu
sandwich
enzymelink
imunosorb
assay
mous
inflamm
kit
bd
pharmingen
san
diego
ca
compar
group
wilcoxon
test
test
fisher
exact
valu
calcul
use
jmp
applic
sa
institut
inc
cari
nc
threeweekold
femal
mice
inocul
bcg
salin
four
day
bcg
immun
nodular
format
observ
mice
inocul
bcg
inocul
salin
tabl
ppd
test
result
erythema
format
increas
venular
appear
anim
inocul
bcg
salineinocul
anim
tabl
four
week
immun
bcg
salin
anim
intraperiton
inocul
cmi
pb
histolog
analysi
perform
week
secondari
inocul
mild
coronari
arter
mononuclear
cell
infiltr
around
arteri
wall
demonstr
six
section
anim
immun
bcg
cmi
bi
fig
tabl
one
section
anim
immun
bcg
alon
tabl
section
anim
immun
cmi
alon
without
bcg
show
coronari
arter
anoth
set
experiment
group
four
booster
tabl
anim
inocul
four
time
daili
cmi
pb
follow
primari
inocul
bcg
salin
result
coronari
arter
includ
one
sever
case
infiltr
arteri
wall
demonstr
significantli
heart
section
anim
bcg
cmi
immun
bi
group
fig
tabl
p
vs
bcg
cmi
immun
perform
independ
coronari
arter
observ
bare
observ
mice
treat
either
bcg
cmi
thu
bcg
immun
follow
multipl
dose
cmi
immun
significantli
induc
coronari
arter
bodi
weight
bodi
temperatur
affect
immun
data
shown
examin
whether
administr
antibodi
peroxiredoxin
ii
induc
coronari
arter
administr
rabbit
antiserum
peroxiredoxin
ii
alon
result
coronari
arter
one
section
examin
tabl
howev
mice
inocul
bcg
prior
antibodi
administr
coronari
arter
develop
section
significantli
higher
frequenc
control
group
p
fig
tabl
similar
observ
bcg
cmi
immun
thu
antibodi
peroxiredoxin
ii
induc
coronari
arter
administ
bcg
immun
ten
day
cmi
pb
inocul
follow
bcg
salin
inocul
sera
obtain
mice
determin
cytokin
level
level
significantli
higher
bcginocul
group
bi
mice
treat
salin
instead
bcg
tabl
p
none
cytokin
elev
anim
inocul
cmi
without
primari
bcg
inocul
compar
level
control
anim
tabl
similarli
administr
antibodi
peroxiredoxin
ii
without
prior
bcg
immun
also
result
elev
cytokin
level
tabl
level
significantli
higher
anim
given
antibodi
peroxiredoxin
ii
follow
bcg
immun
anim
immun
bcg
alon
tabl
p
averag
valu
higher
bi
bp
group
group
although
differ
statist
signific
flare
crust
format
observ
patient
kawasaki
diseas
immun
respons
bcg
might
associ
develop
system
vascul
hallmark
diseas
describ
autoantibodi
peroxiredoxin
ii
human
homolog
mycobateri
found
patient
kawasaki
diseas
sireci
et
al
karasawa
et
al
yokota
et
al
mani
report
also
indic
kawasaki
diseas
associ
infect
suggest
immunopatholog
reaction
trigger
unknown
microbi
agent
might
associ
develop
kawasaki
diseas
hypothes
ubiquit
microorgan
share
crossreact
antigen
bcg
might
induc
immunopatholog
reaction
bcg
vascular
antigen
microorgan
could
candid
long
share
antigen
relat
compon
bcg
endothelium
assumpt
inocul
anim
bcg
twice
instead
use
extract
atyp
mycobacterium
booster
immunogen
demonstr
phenomenon
experiment
mice
microorgan
antigen
close
relat
bcg
use
crude
extract
intracellular
one
abund
atyp
mycobacteria
demonstr
immun
atyp
mycobacterium
compon
follow
bcg
immun
result
signific
coronari
arter
develop
coronari
arter
requir
immun
bcg
secondari
immun
atyp
mycobacterium
compon
model
four
booster
dose
result
effect
superior
one
booster
nonrepl
immunogen
tend
rapidli
degrad
phagocyt
absenc
adjuv
harlow
lane
multipl
immun
might
requir
appar
booster
immun
cytokin
elev
kawasaki
diseas
furukawa
et
al
mauri
et
al
matsubara
et
al
wong
et
al
induc
bcg
immun
mice
inocul
atyp
mycobacteri
antigen
alon
coronari
arter
develop
indic
bcg
immun
may
induc
cytokin
product
provid
cytokin
level
necessari
develop
coronari
arter
idea
also
support
experi
involv
use
antibodi
one
endotheli
compon
administr
antibodi
peroxiredoxin
ii
alon
bare
induc
coronari
arter
anim
first
prime
bcg
administr
antibodi
result
signific
coronari
arter
similar
observ
multipl
cmi
inocul
follow
bcg
immun
seventi
per
cent
kawasaki
diseas
observ
patient
less
year
age
present
shortli
bcg
immun
sever
report
indic
bcg
may
resid
host
year
inocul
gasiorchrzan
clinic
observ
might
support
import
bcg
first
immunogen
immun
modul
provid
circumst
develop
kawasaki
diseas
level
tend
higher
bi
bp
group
group
although
except
level
bp
group
compar
group
differ
statist
signific
immunopatholog
inflamm
may
enhanc
cytokin
product
peroxiredoxin
ii
antioxid
activ
distribut
mani
type
cell
includ
endothelium
locat
cytoplasm
cell
membran
rhee
et
al
lee
et
al
choi
et
al
peroxiredoxin
ii
may
regul
plateletderiv
growth
factor
remodel
choi
et
al
patient
autoimmun
diseas
system
vascul
antibodi
peroxiredoxin
ii
demonstr
karasawa
et
al
thu
peroxiredoxin
ii
might
import
target
system
vascul
molecul
conserv
mammal
microorgan
includ
mycobacteria
hofmann
et
al
antibodi
crossreact
molecul
microbi
infect
might
induc
destruct
endothelium
also
inhibit
function
heal
process
anoth
report
indic
antibodi
hsp
may
caus
crosslink
hsp
molecul
result
subsequ
product
yokota
et
al
thu
autoantibodi
molecul
might
hamper
endotheli
repair
stimul
cytokin
network
might
associ
develop
kawasaki
diseas
molecul
peroxiredoxin
ii
hsp
conserv
mani
microorgan
human
microorgan
possess
homolog
might
also
induc
similar
immunopathogen
reaction
studi
none
anim
develop
coronari
aneurysm
blood
pressur
mice
might
low
allow
develop
aneurysm
flare
crust
format
observ
site
bcg
inocul
cmi
immun
sever
studi
indic
kawasaki
diseas
might
associ
genet
background
takeuchi
et
al
quasney
et
al
nishimura
et
al
ouchi
et
al
fukazawa
et
al
kariyazono
et
al
may
need
examin
host
genet
background
associ
kawasaki
diseas
order
produc
stronger
reaction
might
also
explain
none
anim
febril
approach
investig
infecti
agentsimmunogen
host
factor
might
critic
clarifi
etiolog
kawasaki
diseas
detail
conclus
bcg
inocul
follow
booster
immun
atyp
mycobacterium
antigen
result
coronari
arter
mice
model
may
lead
better
understand
kawasaki
diseas
